Results 61 to 70 of about 548 (160)
Considerable paediatric drug dispensing – A nationwide study of more than 2 million Swedish children
Acta Paediatrica, Volume 113, Issue 9, Page 2147-2154, September 2024.Abstract Aim The aim of the nationwide study was to describe paediatric drug utilisation in Sweden. Methods Drug prescriptions dispensed to all children aged 0–17 years in 2019 were analysed using data from the Swedish National Prescribed Drug Register. Results We retrieved data on 2 180 508 unique children.
Elin Dahlén, Elin Eyfells Kimland
wiley +1 more source
, 2015 Metodes izstrāde un validācija Bromheksīna piemaisījumu satura noteikšanai Bromheksīna sīrupā ar augsti efektīvo šķidruma hromatogrāfiju. Bogorads V., darba vadītāji Nakurte I., Dulmanis A.
Bogorads, Valters
core
, 2021 Background: Bromhexine hydrochloride has been suggested as a TMPRSS2 protease blocker that precludes the penetration of the SARS-CoV-2 into cells. We aimed to assess the preventive potential of regular bromhexine hydrochloride intake for COVID-19 risk ...
Mikhaylov Evgeny N.
core
Clinical Case Reports, Volume 12, Issue 8, August 2024.Key Clinical Message A 46‐year‐old male developed respiratory distress due to asthma‐chronic obstructive pulmonary disease overlap and experienced severe tremor caused by beta2 agonist inhalant. We present our successful experience with tizanidine administration.
Kota Nakajima, Kenji Momo
wiley +1 more source
STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ANALYSIS OF CEPHALEXIN AND BROMHEXINE IN PHARMACEUTICAL DOSAGE FORM [PDF]
, 2017 A simple, precise and rapid RP-HPLC method has been developed and validated for the simultaneous determination of Cephalexin and Bromhexine in pharmaceutical dosage form.
Prasanthi, T +2 more
core +1 more source
Current opportunities for the treatment of respiratory diseases in paediatric practice
Медицинский совет, 2018 Immediacy of the problem of combination therapy of respiratory diseases in paediatric practice is caused by their multifactorial pathogenesis in children and the need to achieve a high clinical effect in the use of drugs at relatively low doses and with ...
V. N. Drozdov +4 more
doaj +1 more source
Respirology Case Reports, Volume 12, Issue 8, August 2024.This is the protocol for the clinical trial ‘A double–blind randomized controlled trial of N‐acetylcysteine (NAC) for the treatment of acute exacerbation of chronic obstructive pulmonary disease’. This study will assess the role of NAC in the treatment of acute COPD exacerbation in terms of clinical, physiological, and laboratory parameters.
Wang Chung Kwok +3 more
wiley +1 more source
Mucolytic Drugs Ambroxol and Bromhexine: Transformation under Aqueous Chlorination Conditions
Bromhexine and ambroxol are among the mucolytic drugs most widely used to treat acute and chronic respiratory diseases. Entering the municipal wastewater and undergoing transformations during disinfection with active chlorine, these compounds can produce
Sergey A. Sypalov +4 more
core +1 more source
, 2015 Darbā ir veikta bromheksīna hidrohlorīda un metilparahidroksibenzoāta kvantitatīvā satura noteikšanas metodes validācija ar AEŠH. Ir apkopota literatūra par bromheksīna hidrohlorīdu un metil parahidroksibenzoātu.Method for determination of assay of ...
Kopeika, Mārtiņš
core
Electron-capture GLC determination of bromhexine in human plasma
, 1980 A specific and sensitive GLC analysis of bromhexine in human plasma is described. After addition of the internal standard and an aqueous triethanolamine solution, bromhexine is extracted at alkaline pH into n-hexane, transferred to an acidic aqueous ...
Vandecasteele-Thienpont, LMR +1 more
core +1 more source